ROCKLATAN 0.02%-0.005% EYE DRP
FDA nonproprietary name: netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%
For 2.5 mL
Pharmacies pay
$348.51 filed
2.5 × $139.40317 per ML
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$332.20 filed
2.5 × $132.88057 per ML, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
0.95× estimated
Medicare paid about what pharmacies pay.
Part D averages every strength and form sold under “Rocklatan” / “Netarsudil Mesylat/Latanoprost” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$405.79 estimated
$348.51 + $52.28 (15%) + $5.00 fee per fill = $405.79
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
ROCKLATAN 0.02%-0.005% EYE DRP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%, under the trade name “Rocklatan”.
FDA gives its dosage form as solution/ drops and its route as ophthalmic; topical.
The labeler, the company named on the label, is Alcon Laboratories, Inc.
FDA’s Established Pharmacologic Class for it is Rho Kinase Inhibitor.
The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 70727-0529-25.
NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $348.51 for 2.5 mL (2.5 × $139.40317 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.
What NADAC measures · NADAC explanation codes
The NDC
- 70727-0529-25 · Alcon Laboratories, Inc. · $139.40317 per ML · eff. 2026-09-23 filed
What Medicare paid
Medicare Part D paid $332.20 for 2.5 mL, at an average of $132.88057 per ML in 2024 (2024-01-01 to 2024-12-31) for “Rocklatan” and “Netarsudil Mesylat/Latanoprost”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 329,580 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 2.5 mL? Is it lower than what I would pay through my insurance?
- How much is in the package I am getting? This page uses 2.5 mL; your package may hold a different amount.
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for ROCKLATAN 0.02%-0.005% EYE DRP labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Rocklatan / Netarsudil Mesylat/Latanoprost: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on brand name.
- Why does this page start at 2.5 mL?
- NADAC prices this product per ML. The FDA NDC Directory’s package description gives 2.5 mL in one package for this product’s NDC (“1 BOTTLE, PLASTIC in 1 CARTON (70727-529-25) / 2.5 mL in 1 BOTTLE, PLASTIC”), so the card starts at one package: 2.5 ML. Change it to match your prescription.